Purple Biotech Fixed Asset Turnover Over Time
PPBT Stock | USD 2.64 0.10 3.65% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Purple Biotech Performance and Purple Biotech Correlation. Purple |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Purple Biotech. If investors know Purple will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Purple Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 81 | Return On Assets (0.29) | Return On Equity (0.45) |
The market value of Purple Biotech is measured differently than its book value, which is the value of Purple that is recorded on the company's balance sheet. Investors also form their own opinion of Purple Biotech's value that differs from its market value or its book value, called intrinsic value, which is Purple Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Purple Biotech's market value can be influenced by many factors that don't directly affect Purple Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Purple Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Purple Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Purple Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Fixed Asset Turnover Analysis
Compare Purple Biotech and related stocks such as Pluri Inc, BioLineRx, and Aridis Pharmaceuticals Fixed Asset Turnover Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PLUR | (0.8056) | 0.1427 | 0.0572 | 0.035 | 0.0373 | 0.3089 | 0.0088 | 0.0088 | 0.0141 | 0.0061 | 0.026 | 0.026 | 0.0345 | 0.045 | 0.0472 |
BLRX | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.5424 | 2.29 | 2.03 |
ENLV | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 1.064 | 0.96 | 0.85 |
ANEB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PMVP | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
BNOX | 6.7831 | 6.7831 | 6.7831 | 6.7831 | 6.7831 | 6.7831 | 10.3329 | 4.3298 | 2.17 | 0.0687 | 0.5583 | 0.5583 | 0.0598 | 0.0688 | 0.0653 |
BPTH | 0.8213 | 0.0212 | 0.0212 | 0.0212 | 0.0212 | 0.0212 | 0.0212 | 0.0566 | 0.0566 | 0.0566 | 0.0566 | 0.0566 | 0.0566 | 0.0651 | 0.0618 |
CING | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
SLNO | 47.4932 | 47.4932 | 47.4932 | 47.4932 | 4.5199 | 4.5199 | 14.1457 | (67.9 K) | (67.9 K) | (67.9 K) | (67.9 K) | (67.9 K) | (67.9 K) | (78 K) | (74.1 K) |
CINGW | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
SABS | 0.3949 | 0.3949 | 0.3949 | 0.3949 | 0.3949 | 0.3949 | 0.3949 | 0.3949 | 0.3949 | 0.3949 | 2.5014 | 1.967 | 0.8435 | 0.0907 | 0.0862 |
CVKD | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
MNPR | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Purple Biotech and related stocks such as Pluri Inc, BioLineRx, and Aridis Pharmaceuticals Fixed Asset Turnover description
My Equities
My Current Equities and Potential Positions
Purple Biotech | PPBT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | Israel |
Exchange | NASDAQ Exchange |
USD 2.64
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.